Cardlytics submits a Form 144 related to the sale or transfer of shares, with the filing dated July 2, according to Investing.com. Form 144 is a regulatory notice used in the United States to disclose certain planned resales of restricted or control securities, typically by company affiliates or other insiders. The notice period and the specific share quantities are contained in the filing details, which the outlet references as “For: 2 July.” The available information provided here does not specify who the beneficial owners are, how many shares are covered, or whether any sales actually occur. It also does not include transaction dates beyond the “for” date, or any price information. Overall, the reports indicate only that the company has filed the regulatory disclosure for the July 2 reference date.